University of Cincinnati Adds Master s Program in Clinical and Translational Research
The program was approved by the UC Board of Trustees in September and is currently under review by the Ohio Board of Regents.
For the past 20 years, the medical community has become increasingly concerned about the reluctance of young physicians to seek additional training and pursue clinical research, says Erin Haynes, DrPH, an epidemiologist with UCs environmental health department and the programs director. We have fewer physicians pursuing careers in clinical research and an unacceptably high attrition rate for accomplished clinical investigators currently practicing.
The Association of American Medical Colleges says there is an urgent need for medical schools and teaching hospitals to create new models for clinical research training and provide a nurturing environment in which the next generation of physician-scientists can conduct high-quality research.
Haynes says the UC masters program was designed to give students in-depth training in epidemiology, study design, biostatistics, ethical issues and many other areas related to helping physician-scientists master the challenges of conducting clinical research in the next decade.
Our masters program fills a void in training that physicians are asking forand needto be effective clinical investigators who make smart decisions when conducting clinical research, adds Joel Tsevat, MD, MPH, a UC professor of medicine and director of outcomes research for the internal medicine department.
Formally developed in 2004, the new masters in clinical and translational research builds on existing courses offered through the UC Department of Environmental Health. This includes four specialty areas or tracks led by experts in the
University officials say the 48 credit hour masters program can be completed on a part-time basis in two years and currently has 41 students enrolled: 39 physicians and two pharmacists. It is offered through UCs environmental health department and is one of only three masters level courses of this kind in
Under Tsevats leadership, UC applied for a K30 clinical research curriculum award from the National Institutes of Health (NIH). In August 2005, UC received a $1.5 million NIH grant that enabled it to add the necessary coursework to complete the masters level curriculum.
Physicians, nurses, pharmacists and other health professionals interested in pursuing evidence-based clinical research are eligible to apply to the masters program.
Curriculum topics include: clinical epidemiology, translational research, clinical effectiveness, biostatistics, clinical research informatics, molecular epidemiology and clinical trials. Upon completion of the program, graduates should be able to develop research hypotheses, specific criteria and methodology for conducting patient-oriented research and understand how to apply contemporary research tools to these clinically relevant areas of investigation.
The UC curriculum includes a combination of instructional coursework, seminars and individual mentoring sessions designed to foster both the analytic and quantitative skills necessary for conducting research. Students must also complete a thesis based upon their own independent clinical, laboratory or field research.
What I love about this program is that it is designed to respect the time constraints of full-time clinicians, says Emily DeFranco, DO, an obstetrician-gynecologist who began participating in the program this summer. Im able to pursue my scientific endeavors and education without compromising my clinical or family obligations.
Many of my mentors were trained in epidemiology and biostatistics. I was in awe of the tools they had at their disposal because it allowed them to be truly independent researchers, she adds.
That was something I quickly sought to emulate, but I also recognized my deficiencies. My base knowledge is sound, but I have a lot to learn when it comes to advanced analytic methods and complex study designs.
For more information on the masters of clinical and translational research, visit www.eh.uc.edu/clinicalresearch.
Joel Tsevat, MD, professor of general internal medicine
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.